Arcturus Therapeutics
ARCT
50 hedge funds and large institutions have $131M invested in Arcturus Therapeutics in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 5 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
260% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 5
113% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 8
46% more capital invested
Capital invested by funds: $89.2M → $131M (+$41.4M)
35% more funds holding
Funds holding: 37 → 50 (+13)
7% more call options, than puts
Call options by funds: $756K | Put options by funds: $707K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$7.72M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$7M |
| 3 |
PA
Perceptive Advisors
New York
|
+$6.61M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$5.19M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$4.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VM
VHCP Management
New York
|
-$6.53M |
| 2 |
HCM
Hayman Capital Management
Dallas,
Texas
|
-$3.78M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$1.22M |
| 4 |
SIM
Spark Investment Management
New York
|
-$347K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$230K |
ARCT Hedge Fund Activity: Q4 2015 in Review
50 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q4 2015, worth a combined $131M — up 46% from $89.2M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ARCT positions and 5 closed out — a net gain of 13 holders — while 17 added to existing stakes and 8 trimmed.
The largest buyer was RA Capital Management, adding an estimated $7.72M. The largest seller was VHCP Management, cutting an estimated $6.53M.
- 50 institutional investors held Arcturus Therapeutics (ARCT) as of Q4 2015, up from 37 in Q3 2015.
- Funds reported $131M of Arcturus Therapeutics stock for Q4 2015, up 46% quarter-over-quarter.
- 18 funds opened new Arcturus Therapeutics positions in Q4 2015 and 5 closed out, a net change of +13 holders.
- The largest Arcturus Therapeutics buyer in Q4 2015 was RA Capital Management, an estimated $7.72M added.
- The largest Arcturus Therapeutics seller in Q4 2015 was VHCP Management, an estimated $6.53M sold.
Based on aggregated 13F filings for Q4 2015.